PharmD or PhD in a scientific discipline preferred.
15+ years of hands-on Regulatory Affairs experience in biotech.
Proven success leading major FDA interactions and managing expedited pathways.
Strong knowledge of orphan drugs and pediatric drug development regulations.
Recent experience in leading a successful BLA submission resulting in accelerated approval is a major plus.
In-depth mastery of FDA guidelines for ATMPs in rare/pediatric diseases is essential.
Managerial experience.
Responsibilities
Serve as senior advisor to the US Regulatory Lead and Program Regulatory Teams.
Collaborate with Global Regulatory Lead and Regulatory CMC team for consistent global strategies.
Oversee preparation of US regulatory documentation and strategic filings to FDA.
Guide US Regulatory Leads in preparing cross-functional teams for FDA meetings.
Anticipate FDA reactions and develop proactive risk-mitigation plans.
Lead post-approval activities for Lenmeldy® in compliance with FDA requirements.
Participate in regulatory intelligence and support policy activities.
Benefits
Hybrid work model with options for remote work.
Opportunity for professional development and mentoring.
Engagement in strategic leadership and high-impact regulatory activities.
Collaboration with cross-functional and global teams.
Involvement in innovative gene therapy projects.
Full Job Description
Location: Hybrid, Cambridge (MA) or Remote, US Eastern
Reporting to: VP, Regulatory Science
JOB SUMMARY
The Executive Director (ED), Regulatory Science plays a pivotal role in ensuring global alignment on regulatory strategies to meet corporate goals across Orchard's investigational and approved ex vivo HSC gene therapies throughout the different phases of lifecycle (i.e. development, registration and post-approval). As a US Regulatory Science subject matter expert, this position is instrumental in optimizing US regulatory strategies, maintaining high submission standards and fostering strong, collaborative relationships with the US FDA.
Strategic Leadership & FDA interactions
Serve as senior advisor actively supporting the assigned US Regulatory Lead (US RL) and the Program Regulatory Teams defining optimized US regulatory strategies across the entire pipeline;
Closely collaborate with the Global Regulatory Lead (GRL), the Regulatory CMC team and the VP of Regulatory Science, to ensure a consistent global approach is used for the development and execution of regulatory strategies;
Oversee preparation of US regulatory documentation; review meeting requests/briefing documents and other strategic regulatory filings to FDA across programs (e.g. INDs, orphan/fast track/RMAT designation requests, BLAs).
Provide oversight and guidance to US RLs, in preparation of Orchard's cross-functional teams for FDA meetings, supporting meeting conduct, and ensuring effective communication with the Agency across programs.
Leverage experience and insights to anticipate FDA's reactions, interpret Agency's requests and develop actionable proactive risk-mitigation plans.
Lead/manage post-approval activities and commitments for Lenmeldy® in compliance with FDA requirements.
Regulatory Intelligence & Compliance
Actively participate in Regulatory intelligence and support Regulatory policy activities, with a focus on US topics
monitoring, identification, assessment, impact analysis and dissemination of relevant regulatory and competitive landscape updates;
participation in relevant US/international industry associations discussions to advocate on critical pieces of regulation for Orchard's portfolio.
Quality assurance applied to regulatory science activities and regulatory compliance
accountable for ensuring team's adherence to GxP, as well as all relevant Orchard policies and SOPs;
oversee the implementation of new applicable US regulations relevant to development programs;
oversee the US Regulatory Lead activities for FDA inspection readiness.
People & Resource Management
Line management and mentoring of a team of 3-5 regulatory professionals, supporting their individual development plans.
Optimize resources by partnering with the VP, Regulatory Science to define headcount needs, lead recruitments, and manage external vendors.
Manage budget targets, and contribute to the development of the department's annual operating plan (AOP).
Flexible Duties
May act as GRL/US RL on specific program(s) if necessary (e.g. for a new program until resource/budget need can be filled in):
represent the regulatory function on related cross-functional program team(s)
partner with the program lead and development team (research, preclinical, and/or clinical depending on the stage of the program) to build development strategy intended to support regulatory approval(s)
collaborate closely with the Reg CMC lead for the development of successful regulatory strategy associated with the CMC development
lead the program regulatory team towards the execution of all planned and relevant regulatory activities globally (i.e. including but not limited to EU and US).
regulatory liaison with academic partners and coordination of regulatory activities with them as appropriate
May participate in business development initiatives for new programs if relevant.
International travels (mostly to the UK/EU) as needed.
Requirements
REQUIRED KNOWLEDGE AND EXPERIENCE
Education: PharmD or PhD in a scientific discipline preferred.
Experience: 15+ years of hands-on Regulatory Affairs experience in biotech, spanning US regulatory science activities associated with the different phases of drugs lifecycle (i.e. development, registration and post-approval), including
meetings with FDA, INDs, regulatory designations and expedited programs (orphan, fast track, RMAT, breakthrough, accelerated approval pathway...), pediatric study plans, BLA/NDA, post-approval modifications, annual reports and supplements.
some knowledge and experience of the US MLR review of AdPromo materials would be a plus.
FDA Track Record: Proven success leading major FDA interactions (Pre-IND, EOP2, Pre-BLA, Advisory Committees) and managing expedited pathways (RMAT, Accelerated Approval).
Regulatory Expertise: Strong knowledge of orphan drugs development and registration regulations, pediatric drug development and registration, preclinical and clinical development of cell and gene therapies is highly desired (Regulatory CMC technical expertise is not required).
BLA Success: Recent experience in leading a successful BLA submission resulting in accelerated approval is a major plus.
Regulatory Intelligence: In-depth mastery of FDA guidelines relevant for development of ATMPs in rare/pediatric diseases is a must; familiarity with EMA regulations is highly desired; genuine interest for US regulatory policy activities is expected.
Managerial experience.
SKILLS
Resilient & Hands-On: A solutions-driven, "can-do" regulatory professional who balances strategic oversight with a willingness to "roll up their sleeves" in a fast-paced environment.
Influential Communicator: Exceptional written and verbal presentation skills to influence cross-functional stakeholders and build credibility with the FDA.
Strategic and innovative thinker: Forward-looking mindset to problem-solving, with the maturity to make sound, independent recommendations to senior executive leadership.
Cross-Cultural Collaborator: Proven ability to build strong relationships and work seamlessly across global, remote, and multi-cultural teams.
Accountable: Highly dependable, detail-oriented, and driven by strong professional integrity.
About Orchard Therapeutics plc
Orchard Therapeutics is a biotechnology company that develops gene therapies for rare diseases. The company's gene therapy approach seeks to transform a patient's own blood stem cells into a gene-modified drug product to treat the patient's disease. Orchard's pipeline includes treatments for primary immune deficiencies, inherited metabolic disorders, and blood disorders. The company was founded in 2015 and is headquartered in London, UK.